Results: Both copper‐64- and copper‐67-labeled versions of NODAGA-TATE and NODAGA-cLAB4‐TATE showed similar SSTR2 binding affinity, but faster release from tumor cells compared to the clinical reference [177Lu]Lu‐DOTA-TATE. This evidence concerns the gene SSTR2 and neoplasm.